Significant Advance Reported in the Battle against Multidrug-Resistant Bacteria

Researchers from the Novo Nordisk Foundation Center for Biosustainability at the Technical University of Denmark report that antibiotic-resistant Pseudomonas infections in cystic fibrosis (CF) patients show predictable sensitivities to other classes of antibiotics. The scientists believe that this finding could lead to new ways of optimizing treatments for chronic infections."Our discovery of widespread antibiotic sensitivities in the multidrug-resistant pathogen Pseudomonas aeruginosa opens up